Ameritas Investment Partners, Inc. Immunity Bio, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $3.05 Billion
- Q2 2025
A detailed history of Ameritas Investment Partners, Inc. transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 23,485 shares of IBRX stock, worth $55,424. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,485
Previous 13,724
71.12%
Holding current value
$55,424
Previous $41,000
51.22%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding IBRX
# of Institutions
281Shares Held
121MCall Options Held
2.49MPut Options Held
3.14M-
Vanguard Group Inc Valley Forge, PA21.8MShares$51.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$27 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC8.76MShares$20.7 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.76MShares$18.3 Million0.36% of portfolio
-
Jane Street Group, LLC New York, NY7.72MShares$18.2 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $945M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...